ClinicalTrials.Veeva

Menu

Tracking of Upper Limb Sensory and Motor Recovery in Asian Stroke Survivors

T

Tan Tock Seng Hospital

Status

Enrolling

Conditions

Stroke

Treatments

Other: Clinical and technological-aided assessments and questionnaires

Study type

Observational

Funder types

Other

Identifiers

NCT05322837
DSRB 2021/00919

Details and patient eligibility

About

As Singapore's population is aging rapidly, the incidence rate of stroke has been increasing in the past years. Rehabilitation is essential for the resumption of daily activities, and with the appropriate care, it is possible for stroke-survivors to regain most of their functions.

Hence, this study aims to better understand upper limb recovery covering different stages post-stroke in a representative cohort of Asian adults

Full description

Stroke is a leading contributor to disability in Singapore, partially driven by a reduced ability to use the upper limb in their daily lives. Reduced upper limb use commonly results from a variety of impairments such as motor, sensory and cognitive impairments.

The aim of this longitudinal and observational study is to gather a rich multi-modal database on the time-course of upper limb recovery in a representative cohort after stroke and characterise the relationship between upper limb recovery, common post-stroke impairments and quality of life.

Enrollment

400 estimated patients

Sex

All

Ages

21 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Stroke confirmed by neurologists, neurosurgeons and brain imaging (CT, CT angiogram, MRI, MR angiogram)
  2. First ever confirmed stroke
  3. Asian ethnicity
  4. Age 21-90 years
  5. Montreal Cognitive Assessment (MOCA) scores 21/30 and above
  6. Admission to rehabilitation ward is within 8 weeks of stroke onset

Exclusion criteria

  1. Recurrent stroke or transient ischaemic attack (TIA)
  2. Upper limb impairment not related to stroke: e.g., subarachnoid haemorrhage, traumatic brain injury or brain tumours
  3. Bilateral upper limb impairment.
  4. Uncontrolled medical conditions such as hypertension, hypotension, diabetes mellitus, unstable angina, cardiac failure or sepsis will be excluded.
  5. Active fractures or arthritis of upper limb joints/bones
  6. Visual Analogue Scale (VAS) pain > 5/10
  7. MOCA < 21/30
  8. Severe behavioural disturbance or agitation or epilepsy or untreated depression
  9. Life expectancy < 6 months
  10. End organ failures on replacements (renal dialysis or renal replacement therapies)
  11. Minimally responsive or unresponsive awareness (vegetative) states
  12. Pregnancy or lactation states
  13. Admission to rehab ward later than 8 weeks post-stroke
  14. (For TMS assessments only) History of epilepsy or seizures, or cranial surgeries, or have metal implants in body or head, or have implanted electronics, or have metallic valve, or skull fracture or brain injury, or head or brain surgeries.

Trial design

400 participants in 1 patient group

Intervention
Treatment:
Other: Clinical and technological-aided assessments and questionnaires

Trial contacts and locations

1

Loading...

Central trial contact

Megan Lau Si En

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems